SF
Publications
221
Views
89 226
Downloads
16 943
Supervised works
4
Items per page
1 - 221 of 221
Title Published in Access level OA Policy Year Views Downloads
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cellsJCI insight
accessLevelPublic
2024 31 28
Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extensionJournal of bone and mineral research
accessLevelPublic
2024 9 8
Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort studyJournal of bone and mineral research
accessLevelRestricted
2024 9 0
Maladies osseuses : ce qui a changé en 2023Revue médicale suisse
accessLevelRestricted
2024 47 2
Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohortsJournal of bone and mineral research
accessLevelPublic
2024 9 6
3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronateJournal of bone and mineral research
accessLevelPublic
2024 46 15
A meta-analysis of previous falls and subsequent fracture risk in cohort studiesOsteoporosis international
accessLevelRestricted
2024 24 0
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 DiabetesJournal of clinical medicine
accessLevelPublic
2023 26 6
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in miceRMD open
accessLevelPublic
2023 145 44
Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ?Revue médicale suisse
accessLevelPublic
2023 31 5
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fractureEuropean journal of endocrinology
accessLevelPublic
2023 181 11
2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper softwareFrontiers in bioengineering and biotechnology
accessLevelPublic
2023 52 40
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsBMJ
accessLevelPublic
2023 31 7
Unusual phosphaturic mesenchymal tumor mimicking osteoid osteomaRadiology case reports
accessLevelPublic
2023 83 43
Biochemical Markers of Bone Fragility in Patients With DiabetesThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2023 49 0
A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed TomographyJournal of bone and mineral research
accessLevelPublic
2023 75 59
The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trialObesity
accessLevelPublic
2023 141 11
Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on boneNature reviews. Rheumatology
accessLevelRestricted
2023 23 0
Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older womenAging Clinical and Experimental Research
accessLevelPublic
2023 90 31
Previous fracture and subsequent fracture risk : a meta-analysis to update FRAXOsteoporosis international
accessLevelPublic
2023 31 7
Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approachBMC geriatrics
accessLevelPublic
2023 39 29
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to PragmatismNutrients
accessLevelPublic
2022 93 69
Romosozumab efficacy and safety in European patients enrolled in the FRAME trialOsteoporosis international
accessLevelPublic
2022 137 49
Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium IntakeNutrients
accessLevelPublic
2022 109 56
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis planOsteoporosis international
accessLevelRestricted
2022 159 0
Fracture risk following an atypical femoral fractureJournal of bone and mineral research
accessLevelPublic
2022 189 208
Regeneration of Craniofacial Bone Induced by Periosteal PumpingTissue engineering. Part C, Methods.
accessLevelRestricted
2022 158 2
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture RiskJournal of bone and mineral research
accessLevelPublic
2022 256 282
Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fracturesCalcified tissue international
accessLevelPublic
2022 285 219
Pathophysiology of vascular calcification and bone loss: linked disorders of ageing?Nutrients
accessLevelPublic
2021 161 98
Primary mouse osteoblast and osteoclast culturing and analysisSTAR protocols
accessLevelPublic
2021 316 153
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patientsClinical chemistry and laboratory medicine
accessLevelPublic
2021 234 93
A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With AgingJournal of Bone and Mineral Research
accessLevelRestricted
2021 145 0
Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult womenOsteoporosis international
accessLevelRestricted
2021 110 0
Covid 19 - vitamine D - traitement de l'ostéoporoseRevue médicale suisse
accessLevelPublic
2021 168 152
Bone fragility in patients affected by congenital diseases non skeletal in originOrphanet Journal of Rare Diseases
accessLevelPublic
2021 162 98
Développement et évaluation des filières de l'ostéoporose en SuisseRevue médicale suisse
accessLevelPublic
2021 244 194
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5DNephrology Dialysis Transplantation
accessLevelRestricted
2021 197 4
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative ReviewAdvances in therapy
accessLevelPublic
2021 120 140
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison servicesOsteoporosis international
accessLevelPublic
2021 185 87
Ostéoporose - Nouvelle molécule, nouvelles directivesRevue médicale suisse
accessLevelPublic
2021 72 24
RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone FragilityJournal of Bone and Mineral Research
accessLevelRestricted
2021 223 1
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic MiceFrontiers in Cell and Developmental Biology
accessLevelPublic
2021 152 64
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment GoalsJBMR plus
accessLevelPublic
2021 130 67
Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus?Calcified tissue international
accessLevelRestricted
2021 184 0
Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional studyJournal of bone and mineral research
accessLevelRestricted
2021 126 0
The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI studyNutrients
accessLevelPublic
2021 132 107
Short or long-term osteoporosis therapy with denosumab ?Journal of clinical endocrinology & metabolism
accessLevelPublic
2021 105 66
Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing AntibodiesJournal of Bone and Mineral Research
accessLevelRestricted
2021 185 0
Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocolBMC Geriatrics
accessLevelPublic
2021 198 64
Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot studyOsteoporosis international
accessLevelRestricted
2021 76 0
Romosozumab : un nouveau traitement de l'ostéoporose sévèreRevue médicale suisse
accessLevelPublic
2021 995 283
Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal womenThe American Journal of Clinical Nutrition
accessLevelRestricted
2020 243 5
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvementOsteoporosis International
accessLevelPublic
2020 244 118
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Swiss Medical Weekly
accessLevelPublic
2020 376 193
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFThe Journal of clinical endocrinology and metabolism
accessLevelPublic
2020 102 97
Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture riskOsteoporosis International
accessLevelRestricted
2020 190 0
Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI studyJournal of Bone and Mineral Research
accessLevelPublic
2020 173 336
OstéoporoseRevue médicale suisse
accessLevelPublic
2020 75 145
Hand grip strength and early mortality after hip fractureArchives of Osteoporosis
accessLevelRestricted
2020 153 0
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extensionBone
accessLevelRestricted
2020 294 2
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedBone
accessLevelRestricted
2020 247 2
Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No ConfidenceJournal of Bone and Mineral Research
accessLevelRestricted
2020 237 5
The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy studyClinical Interventions in Aging
accessLevelPublic
2020 290 94
T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trialJournal of Bone and Mineral Research
accessLevelPublic
2020 231 62
Vitamin K and OsteoporosisNutrients
accessLevelPublic
2020 164 188
Fracture risk following intermission of osteoporosis therapyOsteoporosis International
accessLevelRestricted
2019 262 1
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentJournal of Clinical Endocrinology and Metabolism
accessLevelRestricted
2019 292 1
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone massJournal of Clinical Investigation
accessLevelPublic
2019 369 322
Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and womenOsteoporosis International
accessLevelRestricted
2019 259 1
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective studyThe Lancet Diabetes & Endocrinology
accessLevelRestricted
2019 318 0
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against OsteoporosisOsteoporosis International
accessLevelRestricted
2019 297 1
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for OsteoporosisAdvances in Therapy
accessLevelPublic
2019 246 127
Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab TreatmentJournal of Bone and Mineral Research
accessLevelPublic
2019 278 140
Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatientsOsteoporosis International
accessLevelRestricted
2019 276 1
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific RegionJournal of Clinical Densitometry
accessLevelPublic
2019 232 140
Diabetes and fracture riskPrimer on the metabolic bone diseases and disorders of mineral metabolism
accessLevelRestricted
2019 268 3
Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity studyClinical Interventions in Aging
accessLevelPublic
2018 522 207
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its ExtensionJournal of Bone and Mineral Research
accessLevelRestricted
2018 401 1
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeJournal of Bone and Mineral Research
accessLevelRestricted
2018 390 0
Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal WomenJournal of Bone and Mineral Research
accessLevelRestricted
2018 571 0
Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal womenOsteoporosis International
accessLevelRestricted
2018 415 6
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in miceAmerican Journal of Physiology. Endocrinology and Metabolism
accessLevelRestricted
2018 360 4
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructureOsteoporosis International
accessLevelRestricted
2018 546 1
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabJournal of Bone and Mineral Research
accessLevelRestricted
2018 374 0
Osteoporosis: Romosozumab to rebuild the foundations of bone strengthNature Reviews Rheumatology
accessLevelRestricted
2018 420 0
OstéoporoseRevue médicale suisse
accessLevelRestricted
2018 292 2
Phosphate wasting disorders in adultsOsteoporosis International
accessLevelRestricted
2018 377 1
Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot StudyFrontiers in Pharmacology
accessLevelPublic
2018 467 196
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in miceBone
accessLevelRestricted
2018 375 2
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective StudyJournal of Bone and Mineral Research
accessLevelRestricted
2018 487 3
Ostéoporose chez l'insuffisant rénal: quelle évaluation et quel traitement? Place de la biopsie osseuseRevue médicale suisse
accessLevelRestricted
2018 346 1
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone MetastasisCalcified Tissue International
accessLevelRestricted
2018 335 0
Prevention of fractures in patients with osteoporosisThe Lancet
accessLevelRestricted
2018 429 1
Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallersEuropean Review of Aging and Physical Activity
accessLevelPublic
2018 415 169
OstéoporoseRevue médicale suisse
accessLevelPublic
2018 377 100
Diagnosis and management of bone fragility in diabetes: an emerging challengeOsteoporosis International
accessLevelPublic
2018 362 196
Les métamorphoses du traitement de l'ostéoporoseRevue médicale suisse
accessLevelPublic
2017 355 14
Evaluation of hip abductor and adductor strength in the elderly: a reliability studyEuropean review on aging and physical activity
accessLevelPublic
2017 454 202
Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAXJournal of Bone and Mineral Research
accessLevelRestricted
2017 487 0
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical BoneCalcified Tissue International
accessLevelRestricted
2017 483 1
Cathepsin K Controls Cortical Bone Formation by Degrading PeriostinJournal of Bone and Mineral Research
accessLevelRestricted
2017 425 1
IOF Compendium of Osteoporosis
accessLevelPublic
2017 1 013 394
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal womenThe American journal of clinical nutrition
accessLevelRestricted
2017 585 3
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyBMC musculoskeletal disorders
accessLevelPublic
2017 450 190
Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonatesOsteoporosis International
accessLevelRestricted
2017 464 2
Mechanisms of diabetes mellitus-induced bone fragilityNature reviews. Endocrinology
accessLevelRestricted
2017 471 0
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCOSwiss Medical Weekly
accessLevelPublic
2017 421 202
Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in MalesThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2017 492 0
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC)Inflammatory Bowel Diseases
accessLevelRestricted
2017 523 1
Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitementSwiss Medical Forum
accessLevelRestricted
2017 343 1
Diabetes and BoneCalcified tissue international
accessLevelRestricted
2017 416 1
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingOsteoporosis International
accessLevelRestricted
2017 422 0
hypophosphatasie de l'adulteRevue médicale suisse
accessLevelRestricted
2017 445 6
Jusqu'où et jusqu'à quand traiter l'ostéoporose?Revue médicale suisse
accessLevelPublic
2017 366 97
Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males?Journal of Bone and Mineral Research
accessLevelRestricted
2017 467 0
Within and across-sex inheritance of bone microarchitectureThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2017 1 478 10
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosisTherapeutic advances in musculoskeletal disease
accessLevelRestricted
2016 487 0
Le traitement séquentiel présente des avantagesLeading Opinions. Médecine Interne
accessLevelRestricted
2016 359 1
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analysesBoneKEy Reports
accessLevelPublic
2016 358 145
Traitement de l'ostéoporose : quel médicament et pour qui?La gazette médicale - info@gériatrie
accessLevelPublic
2016 472 674
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in MiceCalcified tissue international
accessLevelRestricted
2016 534 3
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent RetireesJournal of bone and mineral research
accessLevelRestricted
2016 557 7
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone ClubOsteoporosis international
accessLevelRestricted
2016 433 0
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureArchives of osteoporosis
accessLevelPublic
2016 458 200
Periostin action in boneMolecular and cellular endocrinology
accessLevelRestricted
2016 376 0
Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitusEuropean journal of endocrinology
accessLevelRestricted
2016 423 1
Occupation-dependent loading increases bone strength in menOsteoporosis international
accessLevelRestricted
2016 622 3
Romosozumab Treatment in Postmenopausal Women with OsteoporosisThe New England journal of medicine
accessLevelPublic
2016 794 1 241
Santé osseuse des retraités genevoisRevue médicale suisse
accessLevelRestricted
2015 478 2
Gene–Diet Interactions on BoneNutrition and Bone Health
accessLevelRestricted
2015 619 1
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 yearsOsteoporosis international
accessLevelRestricted
2015 481 0
Periostin expression contributes to cortical bone loss during unloadingBone
accessLevelRestricted
2015 517 1
Calcinose cutanée associée aux connectivitesRevue médicale suisse
accessLevelRestricted
2015 998 3
Taxonomy of rare genetic metabolic bone disordersOsteoporosis international
accessLevelRestricted
2015 516 0
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone MicrostructureThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2015 573 0
Sauvons l'ostéoporoseRevue médicale suisse
accessLevelRestricted
2015 438 0
Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterationsOsteoporosis international
accessLevelRestricted
2015 546 1
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trialThe Lancet. Diabetes & endocrinology
accessLevelRestricted
2015 506 0
Osteocytic targets in the treatment of osteoporosisOsteoporosis international
accessLevelRestricted
2014 439 0
The role of teriparatide in sequential and combination therapy of osteoporosisSchweizerische medizinische Wochenschrift
accessLevelRestricted
2014 625 1
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal womenBMC musculoskeletal disorders
accessLevelPublic
2014 687 145
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifeneCurrent medical research and opinion
accessLevelRestricted
2014 469 0
Goal-directed treatment of osteoporosis in EuropeOsteoporosis international
accessLevelRestricted
2014 490 1
Future directions for new medical entities in osteoporosisBaillière's best practice & research. Clinical endocrinology & metabolism
accessLevelRestricted
2014 453 0
Fractures ostéoporotiques: pas seulement chez les femmesRevue médicale suisse
accessLevelRestricted
2014 461 0
Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic MiceJournal of bone and mineral research
accessLevelRestricted
2014 593 0
Tracking of Environmental Determinants of Bone Structure and Strength Development in Healthy Boys: An Eight-Year Follow Up Study on the Positive Interaction Between Physical Activity and Protein Intake From Prepuberty to Mid-Late AdolescenceJournal of bone and mineral research
accessLevelRestricted
2014 596 1
Impaired Musculoskeletal Response to Age and Exercise in PPARβ −/− Diabetic MiceEndocrinology
accessLevelPublic
2014 494 401
Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radiusBone
accessLevelRestricted
2013 510 0
Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient MicePloS one
accessLevelPublic
2013 624 301
Effect of a multifactorial fall-and-fracture risk assessment and management program on gait and balance performances and disability in hospitalized older adults: a controlled studyOsteoporosis international
accessLevelPublic
2013 576 402
Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced ColitisThe American journal of pathology
accessLevelRestricted
2013 495 0
Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and WomenThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2013 604 0
Eliminating the need for fasting with oral administration of bisphosphonatesTherapeutics and clinical risk management
accessLevelPublic
2013 557 314
Diabète et ostéoporoseRevue médicale suisse
accessLevelRestricted
2013 452 0
Periostin Deficiency Increases Bone Damage and Impairs Injury Response to Fatigue Loading in Adult MicePloS one
accessLevelPublic
2013 568 298
Peak bone mass and its regulationPediatric Bone, Second Edition
accessLevelRestricted
2012 480 2
A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axisThe Journal of clinical investigation
accessLevelPrivate
2012 662 0
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspectiveJournal of bone and mineral research
accessLevelRestricted
2012 523 0
Osteoporosis in young adults: pathophysiology, diagnosis, and managementOsteoporosis international
accessLevelPublic
2012 625 954
Antidepressant medications and osteoporosisBone
accessLevelRestricted
2012 556 0
Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulationJournal of bone and mineral research
accessLevelRestricted
2012 502 0
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Osteoporosis international
accessLevelRestricted
2012 556 0
Physical activity increases bone mineral density in children with type 1 diabetesMedicine and science in sports and exercise
accessLevelRestricted
2012 612 1
Behandlung der Osteoporose mit DenosumabTherapeutische Umschau
accessLevelRestricted
2012 533 0
Fractures in Healthy Females Followed from Childhood to Early Adulthood Are Associated with Later Menarcheal Age and with Impaired Bone Microstructure at Peak Bone MassThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2012 593 0
Improvement of bone strength with teriparatide: hip as well as spine?IBMS boneKEy
accessLevelRestricted
2012 386 0
Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostinProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2012 588 0
Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesityInternational journal of obesity
accessLevelRestricted
2012 677 5
Effect of music-based multitask training on gait, balance, and fall risk in elderly people: a randomized controlled trialArchives of internal medicine
accessLevelRestricted
2011 615 2
Do RANKL inhibitors (denosumab) affect inflammation and immunity?Osteoporosis international
accessLevelPublic
2011 542 675
Fractures during childhood and adolescence in healthy boys: relation with bone mass, microstructure, and strengthThe Journal of clinical endocrinology and metabolism
accessLevelPublic
2011 592 351
Prévention des chutes par une méthode d'exercice en musique (rythmique Jaques-Dalcroze)Revue médicale suisse
accessLevelRestricted
2011 626 2
Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational studyJournal of bone and mineral metabolism
accessLevelPublic
2011 515 221
Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levelsEuropean journal of endocrinology
accessLevelPublic
2011 548 379
Bisphosphonates in periodontitis: Friend or foe?IBMS boneKEy
accessLevelRestricted
2011 692 0
Denosumab and bisphosphonates: Different mechanisms of action and effectsBone
accessLevelRestricted
2011 633 0
Protéines et croissance osseuseArchives de pédiatrie
accessLevelRestricted
2011 525 1
Pubertal timing and body mass index gain from birth to maturity in relation with femoral neck BMD and distal tibia microstructure in healthy female subjectsOsteoporosis international
accessLevelPublic
2011 593 275
Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in miceThe Journal of nutritional biochemistry
accessLevelRestricted
2011 529 1
Traitement de l'ostéoporose par les agents biologiquesJe veux en savoir plus
accessLevelRestricted
2011 438 0
Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humansJournal of bone and mineral research
accessLevelRestricted
2011 531 0
Decreased bone turnover in children and adolescents with well controlled type 1 diabetesJournal of pediatric endocrinology & metabolism
accessLevelRestricted
2010 568 2
Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitectureOsteoporosis international
accessLevelPublic
2010 545 299
Ostéoporose: du diagnostic ostéodensitométrique à l'évaluation du risque absolu de fractureJournal für Mineralstoffwechsel
accessLevelRestricted
2010 561 3
Pathophysiology of postmenopausal osteoporosisAtlas of Postmenopausal Osteoporosis. Third Edition
accessLevelRestricted
2010 493 0
Exercise and the skeleton: How it works and what it really doesIBMS boneKEy
accessLevelPublic
2010 854 1 258
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKLThe Journal of biological chemistry
accessLevelRestricted
2010 724 0
Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in miceCalcified tissue international
accessLevelRestricted
2010 592 0
Age de la ménarche et risque d'ostéoporose au cours de la vie adulteMises au point cliniques d'endocrinologie, nutrition et métabolisme
accessLevelRestricted
2010 480 2
An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traitsPLOS genetics
accessLevelPublic
2010 1 024 315
Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient miceArthritis and rheumatism
accessLevelRestricted
2010 487 0
β-Arrestin-biased parathyroid hormone ligands: A new approach to the development of agents that stimulate bone formationScience translational medicine
accessLevelRestricted
2009 516 0
The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activityThe Journal of biological chemistry
accessLevelRestricted
2009 566 1
Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weightPloS one
accessLevelPublic
2009 606 443
Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblastsBone
accessLevelRestricted
2009 560 669
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databasesInternational journal of clinical practice
accessLevelRestricted
2009 511 0
Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomyEndocrinology
accessLevelRestricted
2009 551 0
The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarcheThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2009 541 1
Deleterious effect of late menarche on distal tibia microstructure in healthy 20-year-old and premenopausal middle-aged womenJournal of bone and mineral research
accessLevelRestricted
2009 555 0
Continuous broad protection against osteoporotic fractures with strontium ranelateRheumatology
accessLevelRestricted
2009 551 1
Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in miceJournal of bone and mineral research
accessLevelRestricted
2009 525 0
Differentiation of osteoporotic and neoplastic vertebral fractures by chemical shift {in-phase and out-of phase} MR imagingEuropean journal of radiology
accessLevelRestricted
2009 557 0
Adrenergic control of bone remodeling and its implications for the treatment of osteoporosisJournal of Musculoskeletal and Neuronal Interactions
accessLevelRestricted
2008 506 0
PPARG by dietary fat interaction influences bone mass in mice and humansJournal of bone and mineral research
2008 541 0
High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boysJournal of bone and mineral research
accessLevelRestricted
2008 529 0
Secondary prevention of osteoporotic fractures: why not apply the evidence?Schweizerische medizinische Wochenschrift
accessLevelRestricted
2008 501 0
Influence of age at menarche on forearm bone microstructure in healthy young womenThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2008 612 0
Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weightJournal of bone and mineral research
accessLevelRestricted
2008 535 0
Genomewide Association Studies in Osteoporosis: Have We Reached the Bottom of the Ocean or the Tip of the Iceberg?IBMS boneKEy
2008 514 0
Leptin and the sympathetic connection of fat to boneOsteoporosis international
accessLevelRestricted
2008 521 0
Contribution of gender-specific genetic factors to osteoporosis riskAnnals of human genetics
accessLevelRestricted
2008 475 0
Site specificity of fracture prediction in childrenJournal of bone and mineral research
accessLevelRestricted
2008 451 0
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosisJAMA
accessLevelRestricted
2008 543 0
Human genetics of osteoporosisBaillière's best practice & research. Clinical endocrinology & metabolism
accessLevelRestricted
2008 569 2
Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone massCurrent opinion in lipidology
accessLevelRestricted
2005 498 0
LRP5 gene polymorphisms and idiopathic osteoporosis in menBone
accessLevelRestricted
2005 505 0
beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioidsProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2005 513 0
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whitesAmerican journal of human genetics
accessLevelRestricted
2004 506 0
Parathyroid hormone-related protein increases cAMP production in mammary epithelial cellsThe American journal of physiology
accessLevelRestricted
1993 515 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack